The Week’s Edge

Five high-yield ASX dividend stocks, from the beaten-down to the record-breakers. Gross up for franking and the income league runs opposite to the share-price charts.

The 2026 budget scrapped the 50% CGT discount. ASX growth names dropped 8-15% in two weeks while defensive REITs ran. Here is where capital goes next.

There was a big move signalled in the budget this week. It could be just the beginning of a complete overhaul of one of our most crucial industries.
While the country argues…

Three quiet ASX compounders — Biome (BIO), Compumedics (CMP) and Advanced Braking (ABV). One catalyst pending, two just fired. Verdicts, scorecards, and what to watch.

Let me tell you about a chokepoint.
It’s 33 kilometres wide at its narrowest. Two shipping lanes, each barely wider than a football field. Every single day, twenty million barrels…

It’s been a brutal two weeks in the share market.
The US and Israel have picked a fight with Iran in the most brutal of fashions. Bombs, assassinations, and heaps of name calling.

In the computer game Fallout 2, the main mission is to save your tribe from drought. Along the way, you’re offered side quests — optional detours that help you level up, gather…

If you own ASX tech right now, your portfolio probably feels like it’s being used as a stress ball by Dwayne ‘the Rock’ Johnson. The sell-off hasn’t been polite. Nor gradual…

If you’ve been following along with the Explosive Growth portfolio updates, you would have noticed that we’ve been picking some pretty good winners.
At the time of writing this…

The Investosphere is a constant cesspool of noise and misinformation.
Every day there’s a new hot take, a new chart, a new explanation for what just happened. Most of it’s backward-looking.